These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

115 related items for PubMed ID: 7032430

  • 1. Sustained-release implants in the chemotherapy of experimental rodent malaria I. A comparison of the effects of some antimalarials in polydimethylsiloxane matrices.
    Howells RE, Judge BM.
    Ann Trop Med Parasitol; 1981 Oct; 75(5):495-510. PubMed ID: 7032430
    [No Abstract] [Full Text] [Related]

  • 2. Sustained-release implants in the chemotherapy of experimental rodent malaria II. The effects of sulphadiazine, pyrimethamine and cycloguanil in biodegradable polymer matrices.
    Judge BM, Howells RE, Graham NB, McNeill ME.
    Ann Trop Med Parasitol; 1981 Oct; 75(5):511-9. PubMed ID: 7032431
    [No Abstract] [Full Text] [Related]

  • 3. Drug sensitivity of exo-erythrocytic stages in pyrimethamine-resistant Plasmodium berghei.
    Diggens SM, Gregory KG.
    Trans R Soc Trop Med Hyg; 1970 Oct; 64(4):468-9. PubMed ID: 5485600
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Plasmodium falciparum malaria: rosettes are disrupted by quinine, artemisinin, mefloquine, primaquine, pyrimethamine, chloroquine and proguanil.
    Goldring JD, Padayachee T, Ismail I.
    Mem Inst Oswaldo Cruz; 1999 Oct; 94(5):667-74. PubMed ID: 10464415
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The chemotherapy of rodent malaria, XXVIII. The development of resistance to mefloquine (WR 142,490).
    Peters W, Portus J, Robinson BL.
    Ann Trop Med Parasitol; 1977 Dec; 71(4):419-27. PubMed ID: 339857
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Delay in emergence of mefloquine resistance in Plasmodium berghei by use of drug combinations.
    Puri SK, Dutta GP.
    Acta Trop; 1989 Jul; 46(4):209-12. PubMed ID: 2571247
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Daily primaquine is effective for prophylaxis against falciparum malaria in Kenya: comparison with mefloquine, doxycycline, and chloroquine plus proguanil.
    Weiss WR, Oloo AJ, Johnson A, Koech D, Hoffman SL.
    J Infect Dis; 1995 Jun; 171(6):1569-75. PubMed ID: 7769294
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The mosquito transmission of malaria: the effects of atovaquone-proguanil (Malarone) and chloroquine.
    Enosse S, Butcher GA, Margos G, Mendoza J, Sinden RE, Høgh B.
    Trans R Soc Trop Med Hyg; 2000 Jun; 94(1):77-82. PubMed ID: 10748906
    [Abstract] [Full Text] [Related]

  • 18. [New 6-aminoquinolines with antimalarial activity. Test results on schizontocidal and causalprophylactic effects in rodent- and avian malaria (Plasmodium vinckei, P. berghei and P. cathemerium)].
    Fink E, Nickel P, Dann O.
    Arzneimittelforschung; 1970 Nov; 20(11):1775-7. PubMed ID: 5536991
    [No Abstract] [Full Text] [Related]

  • 19. Atovaquone + proguanil: new preparation. Second-line antimalarial combination.
    Prescrire Int; 2002 Oct; 11(61):131-6. PubMed ID: 12378742
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.